Product Name | MF | CAS | Details |
---|
1-((3aS,6R,7aR)-8,8-Dimethyl-2,2-dioxidotetrahydro-3H-3a,6-methanobenzo[c]isothiazol-1(4H)-yl)ethan-1-one | C12H19NO3S | 141993-16-0 | Details |
2-Chloro-5-phenyl-1,3,4-oxadiazole | C8H5ClN2O | 1483-31-4 | Details |
4-Chloro-6-hydrazinylpyrimidine hydrate | C4H7ClN4O | 1588441-21-7 | Details |
4-Methyl-6-nitroindoline | C9H10N2O2 | 1588441-27-3 | Details |
2-(4-(Bromomethyl)phenyl)-5,5-dimethyl-1,3,2-dioxaborinane | C12H16BBrO2 | 143805-78-1 | Details |
5-Methylbenzo[c][1,2,5]thiadiazole | C7H6N2S | 1457-93-8 | Details |
2-(Diethylamino)-N-(2,3-dimethylphenyl)acetamide (Lidocaine Impurity) | C14H22N2O | 142713-08-4 | Details |
Reinecke salt monohydrate | C4H6CrN6S4.H4N.H2O | 13573-17-6 | Details |
1-(3-Methyloxetan-3-yl)ethanone | C6H10O2 | 1363381-04-7 | Details |
2-((2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)methoxy)-3-hydroxypropyl methyl-L-valinate hydrochloride (Ganciclovir Impurity) | C15H25ClN6O5 | 1401562-16-0 | Details |
6-Chloro-1H-indol-3-yl β-D-glucopyranoside | C14H16ClNO6 | 159954-28-6 | Details |
9-((1R,4S)-4-(tert-Butoxymethyl)cyclopent-2-en-1-yl)-N6-cyclopropyl-9H-purine-2,6-diamine (Abacavir Impurity) | C18H26N6O | 1443421-68-8 | Details |
Atogepant Impurity 31 | C17H21F3N2O3 | 1456803-43-2 | Details |
Tetrabutylammonium (dibromoiodide) | C16H36Br2IN | 15802-00-3 | Details |
3,6,9,12-Tetraoxahexadecan-1-ol | C12H26O5 | 1559-34-8 | Details |
1-Ethenyl-4-(1-ethoxyethoxy)benzene | C12H16O2 | 157057-20-0 | Details |
3-Phenoxypiperidine | C11H15NO | 151666-08-9 | Details |
6,6'-Methylenebis(2-bromo-4-chlorophenol) | C13H8Br2Cl2O2 | 15435-29-7 | Details |
3-(Cyclopropylmethoxy)-4-methoxybenzaldehyde | C12H14O3 | 153200-64-7 | Details |
Barium iodide | BaI2 | 13718-50-8 | Details |
(3R,5S)-tert-butyl 6-chloro-3,5-dihydroxyhexanoate (Rosuvastatin Impurity) | C10H19ClO4 | 154026-93-4 | Details |
sodium (S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-5-hydroxy-3-oxohept-6-enoate (Rosuvastatin Impurity) | C22H25FN3NaO6S | 1346606-28-7 | Details |
Mirabegron Impurity 32 | C16H21ClN2 | 1581285-26-8 | Details |
2,2'-((3,3'-(2,4-Di(pyridin-2-yl)cyclobutane-1,3-diyl)bis(1H-indazole-6,3-diyl))bis(sulfanediyl))bis(N-methylbenzamide) (Axitinib Impurity) | C44H36N8O2S2 | 1428728-83-9 | Details |
Magnesium(II) meso-tetraphenylporphine | C44H28MgN4 | 14640-21-2 | Details |
4,4',5,5'-Tetra(pyridin-4-yl)-2,2'-bi(1,3-dithiolylidene) | C26H16N4S4 | 1581771-50-7 | Details |
5-Methylhexane-2,3-dione | C7H12O2 | 13706-86-0 | Details |
(5-((dimethylamino)methyl)furan-2-yl)methanol (Ranitidine Impurity) | C8H13NO2 | 15433-79-1 | Details |
(R)-2-Amino-3-mercapto-2-methylpropanoic acid (hydrochloride) | C4H10ClNO2S | 148766-37-4 | Details |
L-Alanyl-L-Glutamine impurity 1 | C16H27N5O8 | 1402135-16-3 | Details |
1-Benzyl-4-(Boc-amino)piperidine-4-carboxylic acid | C18H26N2O4 | 150435-81-7 | Details |
lithium laurate,99.90% | C12H23LiO2 | 14622-13-0 | Details |
3-Hydroxy-7-methoxy-2-naphthoic acid | C12H10O4 | 143355-56-0 | Details |
4-Bromo-2,6-diiodophenol | C6H3BrI2O | 15459-51-5 | Details |
(S)-4-((3-(2-Aminoethyl)-1H-indol-5-yl)methyl)oxazolidin-2-one (Zolmitriptan Impurity) | C14H17N3O2 | 139264-15-6 | Details |
Bis(2-ethylhexyl) isophthalate | C24H38O4 | 137-89-3 | Details |
2-(Trifluoromethyl)piperidine | C6H10F3N | 154630-93-0 | Details |
(S)-2-amino-3-(4-(aminomethyl)phenyl)propanoic acid | C10H14N2O2 | 150338-20-8 | Details |
(S)-2-((tert-butoxycarbonyl)amino)-3-(furan-2-yl)propanoic acid | C12H17NO5 | 145206-40-2 | Details |
1-Iodopent-1-yne | C5H7I | 14752-61-5 | Details |
3-((Dimethylamino)methyl)-9-methyl-2,3-dihydro-1H-carbazol-4(9H)-one (Ondansetron Impurity) | C16H20N2O | 153139-56-1 | Details |
2-((tert-Butoxycarbonyl)(methyl)amino)benzoicacid | C13H17NO4 | 141871-02-5 | Details |
Pyridine-2,6-diamine sulfate | C5H9N3O4S | 146997-97-9 | Details |
1-(Phenylsulphonyl)piperazine | C10H14N2O2S | 14172-55-5 | Details |
2-(3,5-Dimethyladamantan-1-yl)acetic acid | C14H22O2 | 14202-14-3 | Details |
4,4'-Diphenoxybenzophenone | C25H18O3 | 14984-21-5 | Details |
Methyl petroselaidate | C19H36O2 | 14620-36-1 | Details |
(2S)-2-((2,6-dimethylphenyl)carbamoyl)-1-propylpiperidine 1-oxide | C17H26N2O2 | 1391053-59-0 | Details |
2-(2-Methylthiazol-4-yl)acetic acid | C6H7NO2S | 13797-62-1 | Details |
tert-Butyl 4-(4-formyl-3-hydroxyphenyl)piperazine-1-carboxylate | C16H22N2O4 | 1446332-69-9 | Details |
2-((Tert-butyldiphenylsilyl)oxy)ethan-1-ol | C18H24O2Si | 138499-16-8 | Details |
1,4-Butanediol bis(3-aminocrotonate) | C12H20N2O4 | 14205-47-1 | Details |
1,2-Bis(dimethoxyphosphoryl)benzene | C10H16O6P2 | 15104-46-8 | Details |
Indium(i) bromide | BrIn | 14280-53-6 | Details |
2,3,5,6-Tetramethylterephthalicacid | C12H14O4 | 14458-05-0 | Details |
1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-6-(4-nitrophenyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione | C27H22F2N6O5S | 1589503-96-7 | Details |
2-(1,1-Dioxidothiomorpholino)acetic acid | C6H11NO4S | 155480-08-3 | Details |
7-Chloro-DL-tryptophan | C11H11ClN2O2 | 153-97-9 | Details |
3-(4-Bromophenyl)isoxazole | C9H6BrNO | 13484-04-3 | Details |
Triisopropyl benzene-1,2,4-tricarboxylate | C18H24O6 | 1528-53-6 | Details |
3,7-Dimethyloct-7-en-1-ol,≥85% (mixture of L-citronellol and geraniol) | C10H20O | 141-25-3 | Details |
1,1':3',1''-terphenyl]-3,3'',5,5''-tetracarboxylic acid | C22H14O8 | 1433189-27-5 | Details |
4,4'-(Azanediylbis(methylene))dibenzoic acid | C16H15NO4 | 14900-61-9 | Details |
Dyclonine Impurity 4 | C24H28O4 | 14146-86-2 | Details |
4,5,6,7-Tetrachloro-2-methylisoindoline-1,3-dione | C9H3Cl4NO2 | 14737-80-5 | Details |
Disodium hydrogen phosphite | H4NaO3P | 13708-85-5 | Details |
3,5-Difluoro-4'-propyl-1,1'-biphenyl | C15H14F2 | 137528-87-1 | Details |
Potassium trifluoro(oxetan-3-yl)borate | C3H4BF3KO | 1430219-76-3 | Details |
Formamidine lead iodide | CH8I3N2Pb | 1451592-07-6 | Details |
1,4-bis(benzo[b]thiophen-4-yl)piperazine (Brexpiprazole Impurity) | C20H18N2S2 | 1420987-86-5 | Details |
Tert-butyl 2-((4R,6S)-6-((Z)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate (Pitavastatin Impurity) | C32H36FNO4 | 154170-27-1 | Details |
2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl azide, 98% | C14H19N3O9 | 13992-26-2 | Details |
Barium phosphate | BaH5O4P | 13517-08-3 | Details |
Ethyl 2-(4-acetamidophenyl)acetate | C12H15NO3 | 13475-17-7 | Details |
(S)-3-(Hydroxymethyl)-1-methylpiperazine-2,5-dione | C6H10N2O3 | 155225-26-6 | Details |
5-Carboxy-2′-deoxyuridine | C10H12N2O7 | 14599-46-3 | Details |
3-Amino-1-benzylpyrrolidine-3-carboxylic acid | C12H16N2O2 | 145602-87-5 | Details |
1-Piperidinecarbonitrile | C6H10N2 | 1530-87-6 | Details |
4-Piperazine-piperidine | C9H19N3 | 142013-66-9 | Details |
2-Chlorobenzothioamide | C7H6ClNS | 15717-17-6 | Details |
Benzyl but-3-yn-1-ylcarbamate | C12H13NO2 | 149965-78-6 | Details |
5-(Chloromethyl)-1-methyl-1H-pyrazole hydrochloride | C5H8Cl2N2 | 1434128-56-9 | Details |
2-(2-(4-(9-Chlorodibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol (Quetiapine Impurity) | C21H24ClN3O2S | 1371638-11-7 | Details |
4',4''',4''''',4'''''''-(Ethene-1,1,2,2-tetrayl)tetrakis(N,N-diphenyl-[1,1'-biphenyl]-4-amine) | C98H72N4 | 1416786-56-5 | Details |
Cis-Bis(isothiocyanato)bis(2,2′-bipyridyl-4,4′-dicarboxylato)ruthenium(II) | 2C12H8N2O4.C2N2RuS2 | 141460-19-7 | Details |
3-(Dipropylamino)-4-methoxybenzenesulfonic acid | C13H21NO4S | 153086-37-4 | Details |
7-(3-Buten-1-yloxy)-3,4-dihydro-2(1H)-quinolinone | C13H15NO2 | 1359829-23-4 | Details |
Potassium 9,10-dioxo-9,10-dihydroanthracene-1,8-disulfonate | C14H9KO8S2 | 14938-42-2 | Details |
Sodium 4-Hydroxynaphthalene-2-sulfonate | C10H7NaO4S | 13935-00-7 | Details |
Trimethionine | C15H29N3O4S3 | 14486-15-8 | Details |
(E)-3-(2-fluorophenyl)acrylaldehyde | C9H7FO | 149733-71-1 | Details |
Methyl 3-amino-5-bromo-2-hydroxybenzenecarboxylate | C8H8BrNO3 | 141761-82-2 | Details |
2-Amino-6-fluoro-n-phenylbenzamide | C13H11FN2O | 1417456-04-2 | Details |
3,5-Di(1H-imidazol-1-yl)pyridine | C11H9N5 | 1374155-84-6 | Details |
2,3,4,5,6-Pentafluorobenzophenone | C13H5F5O | 1536-23-8 | Details |
Z-Lys(Tfa)-OH | C16H19F3N2O5 | 14905-30-7 | Details |
2-(5-((1H-1,2,4-Triazol-1-yl)methyl)-1H-indol-3-yl)-N-methylethanamine (Rizatriptan Impurity) | C14H17N5 | 144034-84-4 | Details |
Product Total: Product Page: | ||||
183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 |